» Articles » PMID: 33317760

Role of Pharmacist During the COVID-19 Pandemic: A Scoping Review

Overview
Publisher Elsevier
Specialty Pharmacy
Date 2020 Dec 15
PMID 33317760
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Since the start of the new Coronavirus (COVID-19) outbreak in December 2019, pharmacists worldwide are playing a key role adopting innovative strategies to minimize the adverse impact of the pandemic.

Objectives: To identify and describe core services provided by the pharmacist during the COVID-19 pandemic.

Methods: A literature search was performed in MEDLINE, Embase, Scopus, and LILACS for studies published between December 1st, 2019 and May 20th, 2020 without language restriction. Studies that reported services provided by pharmacists during the COVID-19 pandemic were included. Two independent authors performed study selection and data extraction with a consensus process. The pharmacist's intervention identified in the included studies were described based on key domains in the DEPICT v.2.

Results: A total of 1189 records were identified, of which 11 studies fully met the eligibility criteria. Most of them were conducted in the United States of America (n = 4) and China (n = 4). The most common type of publication were letters (n = 4) describing the workplace of the pharmacist in hospitals (n = 8). These findings showed the different roles of pharmacists during the COVID-19 pandemic, such as disease prevention and infection control, adequate storage and drug supply, patient care and support for healthcare professionals. Pharmacists' interventions were mostly conducted for healthcare professionals and patients (n = 7), through one-to-one contact (n = 11), telephone (n = 6) or video conference (n = 5). The pharmacists' main responsibility was to provide drug information for healthcare professionals (n = 7) as well as patient counseling (n = 8).

Conclusions: A reasonable number of studies that described the role of the pharmacists during the COVID-19 pandemic were found. All studies reported actions taken by pharmacists, although without providing a satisfactory description. Thus, future research with more detailed description as well as an evaluation of the impact of pharmacist intervention is needed in order to guide future actions in this and/or other pandemic.

Citing Articles

Pharmacists' perceptions of the new pharmaceutical vaccination service in Romania: a comprehensive first two-years evaluation.

Buicu C, Naidin M, Chereches M, Dimulescu M, Turcu-Stiolica A Front Pharmacol. 2025; 15():1476504.

PMID: 39840102 PMC: 11747464. DOI: 10.3389/fphar.2024.1476504.


Predictors of Using Pharmacists as a Medication Safety Information Resource Among Women of Reproductive Age.

Awuonda M, Alem G, Olbert B, Reddy M, Daftary M, Wingate L Drug Healthc Patient Saf. 2024; 16:125-132.

PMID: 39664451 PMC: 11633287. DOI: 10.2147/DHPS.S412786.


Knowledge Gap or Prepared Force? Exploring United Arab Emirates Pharmacy Students and Pharmacists' Monkeypox Readiness.

Nassar R, Ahmad A, Basheti I, Omar A, Barqawi H, Alzoubi K Healthcare (Basel). 2024; 12(22).

PMID: 39595492 PMC: 11593419. DOI: 10.3390/healthcare12222295.


Patterns of self-medication and intention to seek pharmacist guidance among older adults during the COVID-19 pandemic in Macao: a cross-sectional study.

Zheng Y, Tang P, Hu H, Ung C BMC Public Health. 2024; 24(1):2066.

PMID: 39085834 PMC: 11293033. DOI: 10.1186/s12889-024-19453-2.


Evolutionary trend analysis of the pharmaceutical management research field from the perspective of mapping the knowledge domain.

Shen J, Wei S, Guo J, Xu S, Li M, Wang D Front Health Serv. 2024; 4:1384364.

PMID: 39055548 PMC: 11269259. DOI: 10.3389/frhs.2024.1384364.


References
1.
Meng L, Qiu F, Sun S . Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China. Int J Clin Pharm. 2020; 42(2):305-308. PMC: 7113541. DOI: 10.1007/s11096-020-01020-5. View

2.
Tan S, Zhang B, Xu P . Chinese pharmacists' rapid response to the COVID-19 outbreak. Am J Health Syst Pharm. 2020; 77(14):1096-1097. PMC: 7239245. DOI: 10.1093/ajhp/zxaa120. View

3.
Kretchy I, Asiedu-Danso M, Kretchy J . Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries. Res Social Adm Pharm. 2020; 17(1):2023-2026. PMC: 7158799. DOI: 10.1016/j.sapharm.2020.04.007. View

4.
Rotta I, Salgado T, Felix D, Souza T, Correr C, Fernandez-Llimos F . Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. J Eval Clin Pract. 2015; 21(4):584-90. DOI: 10.1111/jep.12339. View

5.
Hua X, Gu M, Zeng F, Hu H, Zhou T, Zhang Y . Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. J Am Pharm Assoc (2003). 2020; 60(3):431-438.e1. PMC: 7146685. DOI: 10.1016/j.japh.2020.04.006. View